Product correctly added to cart.

discount label
No image
View 3D

Targetmol logo

Isoxicam

CAS: 34552-84-6

Ref. TM-T0285

1mg
46.00 €
5mg
89.00 €
10mg
114.00 €
25mg
184.00 €
50mg
272.00 €
100mg
407.00 €
200mg
605.00 €
Estimated delivery in United States, on Monday 6 May 2024

Product Information

Name:
Isoxicam
Synonyms:
  • Isoxicamum, Isoxicamo, Maxicam
  • (3E)-3-{hydroxy[(5-methylisoxazol-3-yl)amino]methylidene}-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide
  • (3Z)-3-{hydroxy[(5-methylisoxazol-3-yl)amino]methylidene}-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide
  • 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-, 1,1-dioxide
  • 4-Hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
  • 4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
  • Brn 0577221
  • Floxicam
  • Isoxicam [USAN:INN:BAN]
  • Isoxicamo
  • See more synonyms
  • Isoxicamo [INN-Spanish]
  • Isoxicamum
  • Isoxicamum [INN-Latin]
  • Maxicam
  • Pacyl
  • Pacyl (antiinflammatory)
  • Unii-8Xu734C4Ng
  • Vectren
  • W 8495
Description:

Isoxicam (Isoxicamum) is a non-steroidal anti-inflammatory drug that is not marketed in the United States.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
335.34
Formula:
C14H13N3O5S
Purity:
99.12%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T0285 Isoxicam

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".